SAN DIEGO–(BUSINESS WIRE)– #CancerChallenge–Curebound, a San Diego-based cancer research accelerator, announced the addition of Paula Schneider and Richard Whittington to its board of directors.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
